Dharmacon RNAi Technology Selected by Genentech to support Drug Discovery Research
"We think it is fitting that Dharmacon, a pioneer in RNAi research, has been selected by Genentech, one of the world's leading biotechnology companies, to supply advanced siRNA products and technology for its drug discovery research programs, " said Leland Foster, president and chief executive officer of the Biosciences group of Fisher Scientific International Inc. "We believe this agreement is further indication that Dharmacon's SMARTselection and SMARTpool technologies are a preferred gene-silencing platform for drug discovery research among leading pharmaceutical and biotechnology companies. Dharmacon's continued leadership in the RNAi field and the exceptional potency and specificity of our siRNA reagents make us the supplier of choice for researchers utilizing RNAi technology to accelerate drug discovery."
Most read news
Organizations
Other news from the department business & finance
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.